33,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
17 °P sammeln
  • Broschiertes Buch

This book focuses on promising new biomarkers for diagnosing and treating Autism Spectrum Disorder (ASD). It explores genetic, immunologic, and metabolic markers, including those related to oxidative stress and mitochondrial dysfunction. The book also examines current limitations-such as small sample sizes and lack of specificity-and discusses future applications like multiplex immunoassays and machine learning. Its ultimate aim is to clarify these tools' potential and complexities in developing personalized treatment strategies.

Produktbeschreibung
This book focuses on promising new biomarkers for diagnosing and treating Autism Spectrum Disorder (ASD). It explores genetic, immunologic, and metabolic markers, including those related to oxidative stress and mitochondrial dysfunction. The book also examines current limitations-such as small sample sizes and lack of specificity-and discusses future applications like multiplex immunoassays and machine learning. Its ultimate aim is to clarify these tools' potential and complexities in developing personalized treatment strategies.
Autorenporträt
Dalia Medhat, professor of medical biochemistry at Egypt's National Research Centre, is an expert in medical research and translational science. Her work spans cancer biology, stem cell therapy, nanomedicine, and using natural compounds to treat diabetes, neurodegenerative diseases, and liver disorders.